Hampton G - Search Results

1

Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cells.

Wagner KW, King F, Nomoto K, Knee DA, Hampton G, Nasoff M, Deveraux QL. Wagner KW, et al. Among authors: hampton g. Cancer Biol Ther. 2003 Sep-Oct;2(5):534-40. doi: 10.4161/cbt.2.5.453. Cancer Biol Ther. 2003. PMID: 14614322 Free article.

2

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin.

Wagner KW, Sapinoso LM, El-Rifai W, Frierson HF, Butz N, Mestan J, Hofmann F, Deveraux QL, Hampton GM. Wagner KW, et al. Oncogene. 2004 Aug 26;23(39):6621-9. doi: 10.1038/sj.onc.1207861. Oncogene. 2004. PMID: 15208666

3

Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi.

Deveraux QL, Aza-Blanc P, Wagner KW, Bauerschlag D, Cooke MP, Hampton GM. Deveraux QL, et al. Semin Cancer Biol. 2003 Aug;13(4):293-300. doi: 10.1016/s1044-579x(03)00043-9. Semin Cancer Biol. 2003. PMID: 14563124 Review.

4

RNAi and HTS: exploring cancer by systematic loss-of-function.

Willingham AT, Deveraux QL, Hampton GM, Aza-Blanc P. Willingham AT, et al. Oncogene. 2004 Nov 1;23(51):8392-400. doi: 10.1038/sj.onc.1208217. Oncogene. 2004. PMID: 15517021 Review.

5

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF Jr, Hampton GM. Welsh JB, et al. Among authors: hampton gm. Cancer Res. 2001 Aug 15;61(16):5974-8. Cancer Res. 2001. PMID: 11507037

6

Analysis of replication error (RER+) phenotypes in cervical carcinoma.

Larson AA, Kern S, Sommers RL, Yokota J, Cavenee WK, Hampton GM. Larson AA, et al. Among authors: hampton gm. Cancer Res. 1996 Mar 15;56(6):1426-31. Cancer Res. 1996. PMID: 8640835

7

Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell line.

Wang S, Yan-Neale Y, Fischer D, Zeremski M, Cai R, Zhu J, Asselbergs F, Hampton G, Cohen D. Wang S, et al. Among authors: hampton g. Oncogene. 2003 Sep 18;22(40):6204-13. doi: 10.1038/sj.onc.1206653. Oncogene. 2003. PMID: 13679859

8

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function.

Gandhi AK, Kang J, Capone L, Parton A, Wu L, Zhang LH, Mendy D, Lopez-Girona A, Tran T, Sapinoso L, Fang W, Xu S, Hampton G, Bartlett JB, Schafer P. Gandhi AK, et al. Among authors: hampton g. Curr Cancer Drug Targets. 2010 Mar;10(2):155-67. doi: 10.2174/156800910791054239. Curr Cancer Drug Targets. 2010. PMID: 20088798

9

High resolution analysis of chromosome 3p alterations in cervical carcinoma.

Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM. Larson AA, et al. Among authors: hampton gm. Cancer Res. 1997 Sep 15;57(18):4082-90. Cancer Res. 1997. PMID: 9307297

10

Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β.

Nakanishi Y, Walter K, Spoerke JM, O'Brien C, Huw LY, Hampton GM, Lackner MR. Nakanishi Y, et al. Cancer Res. 2016 Mar 1;76(5):1193-203. doi: 10.1158/0008-5472.CAN-15-2201. Epub 2016 Jan 12. Cancer Res. 2016. PMID: 26759240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters